Baloxavir marboxil (Xofluza) for treatment of influenza.Med Lett Drugs Ther. 2018 Dec 03; 60(1561):193-196.ML
MeSH
Pub Type(s)
Journal Article
Language
eng
PubMed ID
30653474
Citation
"Baloxavir Marboxil (Xofluza) for Treatment of Influenza." The Medical Letter On Drugs and Therapeutics, vol. 60, no. 1561, 2018, pp. 193-196.
Baloxavir marboxil (Xofluza) for treatment of influenza. Med Lett Drugs Ther. 2018;60(1561):193-196.
(2018). Baloxavir marboxil (Xofluza) for treatment of influenza. The Medical Letter On Drugs and Therapeutics, 60(1561), 193-196.
Baloxavir Marboxil (Xofluza) for Treatment of Influenza. Med Lett Drugs Ther. 2018 Dec 3;60(1561):193-196. PubMed PMID: 30653474.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Baloxavir marboxil (Xofluza) for treatment of influenza.
PY - 2019/1/18/entrez
PY - 2019/1/18/pubmed
PY - 2019/2/5/medline
KW - Rapivab
KW - Relenza
KW - Tamiflu
KW - Xofluza
KW - adverse effects
KW - baloxavir marboxil
KW - dosage
KW - drug interactions
KW - efficacy
KW - influenza
KW - neuraminidase inhibitors
KW - oseltamivir
KW - peramivir
KW - pregnancy
KW - safety
KW - zanamivir
SP - 193
EP - 196
JF - The Medical letter on drugs and therapeutics
JO - Med Lett Drugs Ther
VL - 60
IS - 1561
N2 -
SN - 1523-2859
UR - https://www.unboundmedicine.com/medline/citation/30653474/Baloxavir_marboxil__Xofluza__for_treatment_of_influenza_
DB - PRIME
DP - Unbound Medicine
ER -